ADAI News & Events
February 24, 2021
New Factsheet: WA Poison Center Calls for Intentional Exposure to Cannabis, 2017-2020
Washington Poison Center (WPC) receives calls for help about people who used a substance and experienced negative reactions. An increase in poison center calls for cannabis consumption have been documented in legalized states since 2014. Given this increase and the diversification of legalized cannabis products, poison centers began collecting more information on the type of cannabis products…
February 16, 2021
Webinar, March 5: Hepatitis C Treatment in WA – Lummi Tribal Health Center & Statewide HCV Elimination Plan
Washington State has committed to eliminate HCV by 2030. Join us on March 5, 2021 at 10am to learn about: The Lummi Tribal Health Center’s approach to integrating HCV testing and treatment into their harm reduction program. Data from the Department of Health on hepatitis C in WA State. Statewide plan for hepatitis C elimination, including efforts to improve…
February 10, 2021
Washington’s Overdose Deaths Increase Sharply: Fentanyl Availability a Factor
In this interview with KUOW, ADAI Principal Research Scientist Caleb Banta-Green, PhD, MPH, MSW, describes a striking increase in drug overdoses in the first half of 2020 and continuing on into the year. Fentanyl’s increasing availability, typically sold as what looks like prescription Oxycodone pills, is a major contributing factor. “The issue is that because…
February 9, 2021
Webinar, Feb. 24: Parent-Child Assistance Program: Supporting Substance Use Disorder Recovery for Pregnant and Parenting Women
Join the Northwest ATTC on February 24 (12-1pm PT) for this webinar presented by Susan Stoner, PhD, ADAI Research Scientist and Director of the Parent-Child Assistance Program (PCAP) at ADAI. In this session, Dr. Stoner will provide an overview of this award-winning, evidence-informed, 3-year case management intervention and present practice-based evidence of its effectiveness in…
February 5, 2021
Q&A with Dr. Caleb Banta-Green: Fentanyl’s Growth Among Overdoses “Stunning”
In late December, the Centers for Disease Control and Prevention reported that 81,230 Americans had died from a drug overdose in the year that ended in May 2020 — the highest total ever for a 12-month span. The report largely attributed the rise to illegally manufactured fentanyl, an opioid often found in counterfeit oxycodone pills….
February 4, 2021
ADAI’s Marijuana Research, Outreach, and Education Work, 2019-2021
The ADAI Cannabis Workgroup carries out research, outreach, and education projects that respond to emerging needs of Washingtonians in the context of legalized cannabis, with the goal of helping agencies, policymakers, and individuals make decisions and set priorities. Our 2019-2021 Interim Marijuana Research Report describes the studies, collaborative work, and information products completed during the 2019-2021 biennium…
January 22, 2021
Pregnant/Parenting Women and Substance Use Webinar Series, January-March 2021 (Northwest ATTC)
The Northwest ATTC at ADAI will be hosting a 3-part webinar series on pregnant/parenting women and substance use this winter. All sessions are free and attendees of the live events will receive certificates of attendance that can be used to obtain CEU. Part 1: January 27, 2021 | 12-1pm PST | Register hereImproving Outcomes by Recognizing…
January 20, 2021
WATCH: Methamphetamine: Practical Strategies for Harm Reduction and Client Engagement
Methamphetamine use and methamphetamine-involved deaths are increasing in Washington State. This webinar, held on January 19, 2021, reviewed current WA State data on methamphetamine use and offered practical strategies to work more effectively with individuals who use methamphetamine, including how to: Download slides | Watch video This webinar is intended for anyone in Washington State…
January 6, 2021
Substance Use During the Pandemic: How Clinicians Can Help
ADAI Research Scientist Mandy Owens, PhD, is featured in a recent article in APA’s Monitor on Psychology, talking about the rise in opioid and stimulant use during the pandemic, and how psychologists and clinicians can help. Helping a patient struggling with substance use requires different approaches depending on the type of drug being used. Extending…
January 5, 2021
2021 NIDA Summer Research Internship Program – Apply by Feb 12
Application Deadline: February 12, 2021 The NIDA Summer Research Internship Program introduces undergraduate students from underrepresented populations to substance abuse research through internships with NIDA scientists at universities across the United States. The experience may include laboratory experiments, formal courses, data collection activities, data analysis, patient recruitment, patient interviews, manuscript preparation, literature reviews and library research. Internships include…
Previous page Next page
